share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Hart Brett J

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Hart Brett J

艾伯維公司 | 4:持股變動聲明-董事 Hart Brett J
美股sec公告 ·  05/07 18:36
Moomoo AI 已提取核心訊息
Brett J. Hart, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock on May 3, 2024. The transaction was completed at no cost to the recipient, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Hart's direct holdings in AbbVie common stock increased to a total of 18,269 shares. The grant is part of the company's compensation structure and reflects the ongoing commitment to align the interests of its executives with those of its shareholders.
Brett J. Hart, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock on May 3, 2024. The transaction was completed at no cost to the recipient, as per the transaction code 'A', which indicates a grant, award, or other acquisition. Following this transaction, Hart's direct holdings in AbbVie common stock increased to a total of 18,269 shares. The grant is part of the company's compensation structure and reflects the ongoing commitment to align the interests of its executives with those of its shareholders.
與艾伯維公司 [ABBV] 關聯的佈雷特·哈特於2024年5月3日獲得了1,322股普通股。根據交易代碼 “A”,交易是在不向收款人支付任何費用的情況下完成的,該交易表示贈款、獎勵或其他收購。在這筆交易之後,哈特直接持有的艾伯維普通股增加到總共18,269股。該補助金是公司薪酬結構的一部分,反映了保持高管利益與股東利益一致的持續承諾。
與艾伯維公司 [ABBV] 關聯的佈雷特·哈特於2024年5月3日獲得了1,322股普通股。根據交易代碼 “A”,交易是在不向收款人支付任何費用的情況下完成的,該交易表示贈款、獎勵或其他收購。在這筆交易之後,哈特直接持有的艾伯維普通股增加到總共18,269股。該補助金是公司薪酬結構的一部分,反映了保持高管利益與股東利益一致的持續承諾。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息